Back to the main directory
EarningsReview / Equity
- DB Schenker: No schlam dunk by BNP Paribas Exane
- Nice bounce. Now what? by BNP Paribas Exane
- FQ1''24 preview: Consumption model status check by BNP Paribas Exane
- ODDO : European hotel sector: a sequential ramp-up in RevPAR growth (vs 2019) in April by Oddo BHF
- Crayon Group - Still colourful by Danske Bank Equity Research
- Ober - Décroissance, non extrapolable sur le reste de l’exercice by MidCap Partners
- Grenergy - 1Q23 Results: Supportive, minority sale is key driver; Buy by JB Capital Markets
- Chargeurs - Scenario Confirmed by MidCap Partners
- Cantargia - Buy/SEK 14: Uneventful Q1 2023 report, data at ASCO next up by Nordea
- ODDO BHF Small & MIDCAP MORNING NEWS - 24/05/2023 by Oddo BHF
- Custodian Property Income REIT - Strong leasing has delivered targeted dividends by Edison Investment Research
- Q1: Ticketing revenue growth, but what about profits? by BNP Paribas Exane
- Biodexa Pharmaceuticals - Acquisition of Varian Bio to bolster pipeline by Edison Investment Research
- AFT Pharmaceuticals - Near-term goals in sight with FY23 momentum by Edison Investment Research
- Rejlers - Towards the 2025 vision by Danske Bank Equity Research
- Alibaba Health Info Ltd (241 HK) by HSBC
- Finsbury Growth & Income Trust - Performance getting back on track by Edison Investment Research
- Måsøval (Buy, TP: NOK40.00) - Mixed Q1, slightly soft guidance by DnB Markets
- Salmon Evolution (Buy, TP: NOK12.10) - Amoeba issues by DnB Markets
- Seadrill (Buy, TP: NOK550.00) - While waiting for the cash flow by DnB Markets
- Cool Company (Buy, TP: NOK193.00) - Next step – exercising options by DnB Markets
- Hennes & Mauritz (Hold, TP: SEK150.00) - 2024 operating margin in focus by DnB Markets
- BW Energy (Buy, TP: NOK36.00) - Production growth on track by DnB Markets
- Valuation update by DnB Markets
- Dog days of summer by BNP Paribas Exane